Clinical Trials on VRC01 Monoclonal Antibody
Total 435 results
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infection | Monoclonal Antibody, Human | HIV Antibodies | VRC01 Monoclonal Antibody | Neutralizing AntibodyUnited States
-
University of California, San FranciscoRecruitingInfusion Reaction | Monoclonal AntibodyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal AntibodyUnited States
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
National Institute of Allergy and Infectious Diseases...CompletedMonoclonal Antibody, Human | HIV Antibodies | Neutralizing Antibody | Prevention of HIV InfectionUnited States
-
RxCelerate LtdRxCelerate LimitedUnknownMonoclonal Gammopathy of Unknown SignificanceUnited Kingdom
-
Beijing Tongren HospitalNot yet recruitingBiomarker | Monoclonal Antibody | Chronic Rhino-sinusitis | IL-4RChina
-
Rennes University HospitalCompletedMyeloma | Monoclonal Gammopathy | Monoclonal Gammopathy of Undetermined SignificationFrance
-
University Hospital, LilleTakeda; Laboratoire français de Fractionnement et de Biotechnologies; VitalAire; French Healthcare network for rare immune and hematological disorders (MARIH)Not yet recruitingSpecific Antibody Deficiency | Predominantly Antibody Deficiencies
-
Emory UniversityThe Leukemia and Lymphoma SocietyRecruitingWaldenstrom Macroglobulinemia | Light Chain Deposition Disease | IgA Monoclonal Gammopathy | IgG Monoclonal Gammopathy | IgM Monoclonal Gammopathy | Monoclonal Gammopathy | Smoldering Waldenstrom Macroglobulinemia | Gammopathy, Monoclonal | Gammopathy IggUnited States
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
National Institute of CancerologíaNational Heart Institute, Mexico; Pisa S.A de C.VCompletedPalliative Treatment | Cervical Cancer Recurrent or Persistent | Monoclonal Antibody in Cervical Cancer TreatmentMexico
-
University of Milano BicoccaCompletedMonoclonal Gammopathy of Renal SignificanceItaly
-
Dartmouth-Hitchcock Medical CenterCelgene CorporationTerminatedNeuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)United States
-
University of MiamiWithdrawnObesity | Overweight | Monoclonal Gammopathies
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknown
-
Academia Nacional de MedicinaUnknownMonoclonal Gammopathy of Renal SignificanceArgentina
-
Shahid Beheshti University of Medical SciencesRecruitingAntibody-mediated RejectionIran, Islamic Republic of
-
UMC UtrechtBeiGeneNot yet recruitingMonoclonal Gammopathy of Uncertain SignificanceNetherlands
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedAntibody-mediated RejectionFrance
-
Johnson & Johnson Medical, ChinaCompleted
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingAntibody-mediated RejectionChina
-
Farsad EskandaryCharite University, Berlin, Germany; University of Alberta; HI-BioCompleted
-
CSL BehringTerminatedAntibody-mediated RejectionUnited States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
-
Medical University of ViennaCharite University, Berlin, Germany; University of Alberta; CSL BehringCompleted
-
University of ManitobaTerminatedAntibody Mediated RejectionCanada
-
Thomas MuellerUnknownAntibody-mediated Rejection
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
NYU Langone HealthNot yet recruitingAntibody-mediated Rejection | AllosensitizationUnited States
-
PlexisionMedical University of South CarolinaUnknownAntibody-Mediated Graft RejectionUnited States
-
Barry A. BoilsonJanssen Biotech, Inc.Enrolling by invitationAntibody-mediated Rejection | Cardiac TransplantUnited States
-
Oxford University Hospitals NHS TrustRecruiting
-
Zhujiang HospitalNational Natural Science Foundation of ChinaRecruitingMultiple Myeloma | Monoclonal Gammopathies | M-proteinChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingAntibody-mediated Rejection | Kidney TranplantChina
-
Brigham and Women's HospitalAlexion PharmaceuticalsTerminatedAntibody-mediated Rejection | Humoral RejectionUnited States
-
Medical University of ViennaRecruitingLung Transplant Rejection | Antibody-mediated RejectionAustria
-
University Medical Center GroningenRadboud University Medical Center; Maastricht University Medical Center; UMC... and other collaboratorsRecruitingKidney Transplantation | Immunosuppression | Antibody-mediated RejectionNetherlands
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Washington University School of MedicineBristol-Myers Squibb; National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Transplant Rejection | Antibody-mediated RejectionUnited States
-
Medical University of ViennaElisabethinen HospitalTerminatedAntibody-mediated Rejection | Decreased Immunologic ActivityAustria
-
Duke UniversityBristol-Myers SquibbWithdrawnLung Transplant Rejection | Antibody-mediated Rejection
-
London Health Sciences CentreActive, not recruitingAntibody-mediated Rejection | Liver Transplant Failure
-
Peking University First HospitalRecruitingMultiple Myeloma | Amyloidosis | Smoldering Multiple Myeloma | Plasma Cell Leukemia | Cryoglobulinemia | Light Chain Deposition Disease | Castleman's Disease | Heavy Chain Deposition Disease | Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes | Monoclonal Gammopathy of Undetermined... and other conditionsChina
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
Bio Products LaboratoryCompletedPrimary Antibody DeficiencyUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple Myeloma | Monoclonal Gammopathy of Renal SignificanceUnited States
-
CSL BehringICON Clinical ResearchTerminatedAntibody-mediated RejectionKorea, Republic of, United States, New Zealand, Spain, Taiwan, Netherlands, Australia, France, Canada, Belgium, Czechia, Hungary, Sweden, Austria, Germany
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedKidney Transplant Rejection | Antibody-mediated Rejection | AllosensitizationFrance
-
Bio Products LaboratoryCompletedPrimary or Secondary Antibody DeficiencyUnited Kingdom
-
Vastra Gotaland RegionKarolinska University Hospital; The Swedish Research Council; Uppsala University...RecruitingAntibody-mediated RejectionSweden